GRANTS

209 RESULTS

To submit a grant posting, please fill out our web form or download the form so that you can email us at grants@alzforum.org. List the sponsor name, amount, due date, and contact information. This is a free service.

Please Note: We remove grant postings after 6 months. If you would like your listing to be posted longer or taken down sooner, please contact us at grants@alzforum.org.

NINDS Advanced Postdoctoral Career Transition Award to Promote Diversity in Neuroscience Research (K22) - Clinical Trial Required

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Clinical and Translational Science Award U54 (Clinical Trial Optional)

Sponsor: National Center for Advancing Translational Sciences

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: February 2, 2018 for the first receipt date after that Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Planning Grant to Develop Phase III Clinical Trials for Lewy Body Dementia (R34 clinical Trial Not Allowed)

Sponsor: National Institute of Neurological Disorders and Stroke, National Institute on Aging

Award: NIA intends to commit up to $750,000 in FY 2018 to fund up to five awards.

Due Date: March 20, 2018, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 5, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)

Sponsor: National Institutes of Health

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply), by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is February 16, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NINDS Program Project Grant (P01) - Clinical Trial Optional

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NINDS Efficacy Clinical Trials (U01) - Clinical Trial Required

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

NINDS Exploratory Clinical Trials (U01 - Clinical Trials Required)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply by 5 p.m. local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

T1 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)

Sponsor: National Institute on Aging

Award: The NIA intends to commit $6 million for support of SBIR applications submitted to this FOA and companion FOA PAR-16-376. Additional funds may become available in subsequent years, contingent upon the availability of funds and will be announced in Notices published in the NIH Guide to Grants and Contracts.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization.

T2 Translational Research on Aging: Small Business Innovation Awards (R43/R44 Clinical Trial Optional)

Sponsor: National Institute on Aging

Award: The NIA intends to commit $6 million for support of SBIR applications submitted to this FOA and companion FOA PAR-18-183. Additional funds may become available in subsequent years, contingent upon the availability of funds and will be announced in Notices published in the NIH Guide to Grants and Contracts. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size of each award will also vary. The number of awards made will depend on the quality and costs of the applications received.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization.

Development of Socially-Assistive Robots (SARs) to Engage Persons with Alzheimer's Disease (AD) and AD-Related Dementias (ADRD), and their Caregivers (R41/R42 Clinical Trial Optional)

Sponsor: National Institute on Aging

Award: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Due Date: Standard dates apply, by 5 p.m. local time of applicant organization. Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Current Filters

No filters selected

Filter By